4 Things to Watch as Canopy Growth (TSX:WEED) Reports Earnings Next Week

Cannabis giant Canopy Growth (TSX:WEED)(NYSE:CGC) is set to release its financial statements for financial year and fourth-quarter 2019 periods ended March 31, after market on June 20. Here’s what I think investors should pay close attention to while looking at the financial results. This will be the first set of corporate results issued under the new CFO Mike Lee, whom…

Read More

Another Big Marijuana Stock Began Trading This Week

The bigger the cannabis industry in the U.S. becomes, the more competition will make its way onto the equity markets. This week, we saw another key marijuana company begin trading on the Canadian Securities Exchange (CSE). Harborside Inc (CNSX:HBOR) completed a reverse takeover of FLRish, Inc. and Lineage Grow Company Ltd. in order to go public. However, unlike many pot stocks…

Read More

Should You Buy Canopy Growth (TSX:WEED) Ahead of Earnings?

Canopy Growth Corp  (TSX:WEED)(NYSE:CGC) is going to be releasing its quarterly earnings later this month. And with its share price struggling since May, investors might be tempted to buy the stock before it announces its year-end results. Let’s take a closer look at the company to see whether it’s a good idea to buy now. In its last earnings release…

Read More

Why the Aurora Cannabis (TSX:ACB) UFC Partnership Is a Huge Deal

It’s been a tough few months for Aurora Cannabis (TSX:ACB)(NYSE:ACB) investors. After reaching a peak closing price of $13.26 in April, the stock has been on a gradual but noticeable downtrend, following an earnings report that showed high growth but missed analyst expectations. Although the company’s sales jumped 20% quarter over quarter, its net loss was $150 million, showing the company…

Read More

4 Emerging Trends as Aurora Cannabis (TSX:ACB) Targets Operating Profitability

Marijuana player Aurora Cannabis (TSX:ACB)(NYSE:ACB) released its fiscal third-quarter earnings on May 14, and management reiterated an earlier promise for an operating-earnings-positive quarter in the next installment. The company had reported ever-widening operating losses over several quarters in the past, as management went all out on an aggressive acquisitions-led growth spree, but there have been some notable emerging trends that…

Read More

Should You Buy Aurora Cannabis (TSX:ACB) Ahead of Earnings?

Aurora Cannabis (TSX:ACB)(NYSE:ACB) has scheduled a call for May 15 to discuss its latest quarterly results. The company is likely going to post record revenues and show a significant year-over-year increase yet again. The big question, however, is whether investors would be better off buying today or waiting until after the results to purchase the stock. Let’s take a look…

Read More

Should You Give Up on Aphria (TSX:APHA) and Buy Aurora (TSX:ACB)?

This week, Aphria (TSX:APHA)(NYSE:APHA) reported its earnings and analysts were more than shocked at the results. It was a massive letdown for shareholders who had high hopes for the cannabis company. Aphria remains in third place among Canadian marijuana companies, but now some are worrying that it won’t keep that spot for long. Then we have Aurora Cannabis (TSX:ACB)(NYSE:ACB). This company…

Read More

Should You Buy Aphria Inc (TSX:APHA) Stock Before FY 2019 Earnings?

In April, Aphria (TSX:APHA)(NYSE:APHA) became the first cannabis company to report quarterly earnings for 2019. Because the company’s fiscal year ends in the summer, the announcement was technically Aphria’s third-quarter result of FY 2019. The stock market was not impressed. According to Fool contributor Keith Speights, several factors were to blame. First, Aphria was having trouble keeping up with demand.…

Read More